| Literature DB >> 33936817 |
Yuki Sugiyama1, Kazuma Aiba1, Nariaki Arai1, Mariko Ito1, Masatoshi Urasawa1, Chie Hirose1, Ikuko Murakami1, Ryusuke Tanaka1, Tomokatsu Yamada1, Keisuke Iida1, Hiroyuki Nakamura1, Mikito Kawamata1.
Abstract
Intraoperative massive bleeding is associated with high rates of mortality and anesthetic management of massive bleeding is challenging because it is necessary to achieve volume resuscitation and electrolyte correction simultaneously during massive transfusion. We report a case of life-threatening bleeding of more than 80,000 mL during liver transplantation in which real-time QTc monitoring was useful for an extremely large amount of calcium administration for treatment of hypocalcemia. A 47-year-old female with a giant liver due to polycystic liver disease was scheduled to undergo liver transplantation. During surgery, life-threatening massive bleeding occurred. The maximum rate of blood loss was approximately 15,000 mL/hr and the total amount of estimated blood loss was 81,600 mL. It was extremely difficult to maintain blood pressure and a risk of cardiac arrest continued due to hypotension. In addition, even though administration of insulin and calcium was performed, electrolyte disturbances of hyperkalemia and hypocalcemia with prolongation of QTc interval occurred. At that time, we visually noticed that the QT interval was shortened in response to bolus calcium administration, and we used the change of real-time QTc interval as a supportive indicator for calcium correction. This monitoring allowed for us to administer calcium at an unusually high rate, by which progression of hypocalcemia was prevented. Levels of hemoglobin and coagulation factors were preserved both by restriction of crystalloid infusion and by a massive transfusion protocol. The patient was extubated without pulmonary edema or cardiac overload and was finally discharged without any sequelae. Intensive and cooperative management for massive transfusion and electrolyte correction using QTc monitoring was considered to be a key for successful management.Entities:
Year: 2021 PMID: 33936817 PMCID: PMC8062170 DOI: 10.1155/2021/6635696
Source DB: PubMed Journal: Case Rep Anesthesiol ISSN: 2090-6390
Figure 1Preoperative images of computed tomography showing a massively enlarged polycystic liver that occupied the abdominal space and compressed the diaphragm and abdominal wall. (a) Coronal section. (b) Axial section.
Figure 2Overview of the anesthetic chart. The dosages of drugs are shown in the upper part. Serial changes in QTc interval (QTc), Ca2+, cardiac index (CI), hemodynamics, and body temperature (BT) are shown in the middle part. Approximate amounts of blood loss and transfusion (mL/hr) are shown in the bottom part. Time indicates time after the start of surgery. The double circles indicate the start and end of the surgery. HR, heart rate; bpm, beats per minute; BP, blood pressure; FFP, fresh frozen plasma; RBC, red blood cell concentrates; PC, platelet concentrates.
Figure 3Changes in the electrocardiogram due to electrolyte abnormalities. Upper part: one hour after the start of surgery. Middle part: five hours after the start of surgery. Bottom part: nine hours after the start of surgery. The unit of K+ is mEq/L, the unit of Ca2+ is mg/dL, and the unit of QTc is msec.
Representative laboratory data.
| Normal range | Time (hr:min) | |||||||
|---|---|---|---|---|---|---|---|---|
| Pre | 3:30 | 5:10 | 6:50 | 10:00 | 14:00 | 16:40 | ||
| FiO2 | 0.4 | 0.4 | 0.6 | 0.4 | 0.4 | 0.4 | 0.4 | |
| pH | 7.35–7.45 | 7.53 | 7.32 | 7.16 | 7.28 | 7.35 | 7.40 | 7.42 |
| PaCO2 (mmHg) | 35.0–45.0 | 33.8 | 40.8 | 39.7 | 42.7 | 34.0 | 36.3 | 38.5 |
| HCO3− (mEq/L) | 22–28 | 28.3 | 20.2 | 13.6 | 19.6 | 18.4 | 21.8 | 24.2 |
| PaO2 (mmHg) | 171 | 189 | 240 | 186 | 200 | 193 | 197 | |
| BE (mEq/L) | −2.4–+2.3 | 5.7 | −5.1 | −14.0 | −6.1 | −6.1 | −2.1 | 0.2 |
| Ca2+ (mg/dL) | 4.6–5.3 | 4.4 | 4.3 | 2.1 | 2.5 | 3.6 | 3.7 | 4.4 |
| Na+ (mEq/L) | 135–145 | 139 | 138 | 138 | 148 | 148 | 148 | 149 |
| K+ (mEq/L) | 3.6–4.8 | 4.0 | 5.5 | 6.3 | 4.6 | 4.5 | 4.4 | 4.4 |
| Glu (mg/dL) | 73–140 | 94 | 195 | 232 | 244 | 232 | 201 | 171 |
| Lac (mg/dL) | 4–16 | 7 | 24 | 48 | 46 | 43 | 33 | 30 |
| Hb (g/dL) | 12–16 | 9.3 | 8.5 | 10.4 | 8.0 | 7.7 | 10.8 | 9.4 |
| Plt (×104/ | 15–35 | 23.7 | 4.8 | 0.8 | 10.8 | 3.9 | 7.0 | 10.2 |
| PT-INR | 0.85–1.15 | 1.28 | 1.17 | 1.26 | 1.14 | 1.09 | ||
| APTT (second) | 23–38 | 33.0 | 32.7 | 43.6 | 32.2 | 27.5 | ||
| FIBG (mg/dL) | 180–350 | 367 | 163 | 116 | 228 | 233 | ||
| Blood loss (mL/hr) | 6,120 | 15,500 | 9,000 | 6,150 | 1,000 | 0 | ||
Time indicates time after the start of surgery. Blood loss indicates approximate amount of blood loss per hour. Pre indicates preoperative data. FiO2, fraction of inspiratory oxygen; PaCO2, partial pressure of carbon dioxide; PaO2, partial pressure of arterial oxygen; BE, base excess; Glu, glucose; Hb, hemoglobin, Lac, lactate; Plt, platelet; PT-INR, prothrombin time-international normalized ratio; APTT, activated partial thromboplastin time; FIBG, fibrinogen.
Figure 4Correlation between Ca2+ and QTc interval. R2 indicates coefficient of determination.